01:14 PM EST, 12/10/2024 (MT Newswires) -- CervoMed ( CRVO ) said Tuesday that a phase 2b trial assessing neflamapimod to treat people with dementia with Lewy bodies failed to meet its primary or key secondary endpoints.

Shares slumped 77% as intraday trading volume soared to over 6.44 million from a daily average of about 122,000.

MEDIROM Healthcare Technologies ( MRM ) shares tumbled 45% amid heavy trading after the company unveiled late Monday an offering of 2.86 million American Depositary Shares at $1.75 each, targeting gross proceeds of about $5 million.

More than 1.51 million shares traded intraday compared with a daily average of about 117,000.

Biora Therapeutics ( BIOR ) said in a regulatory filing Tuesday that Nasdaq has determined to delist its securities for failing to comply with the market value of listed securities requirement.

Shares sank 60%, with intraday trading volume at over 1.39 million versus a daily average of about 88,000.

Price: 2.36, Change: -7.89, Percent Change: -76.98